Immunotherapy Today

Immunotherapy News From Around The World

CAR-T immunotherapy shows early signs of promise against some solid tumors – WITI FOX 6 Milwaukee

Posted by btwatson on April 1, 2019 3:06 am
Tags:
Categories: Crispr Articles

Source: CAR-T immunotherapy shows early signs of promise against some solid tumors – WITI FOX 6 Milwaukee

[unable to retrieve full-text content]

  1. CAR-T immunotherapy shows early signs of promise against some solid tumors  WITI FOX 6 Milwaukee
  2. New immnotherapy can shrink otherwise untreatable breast, lung and mesothelioma tumors  Daily Mail
  3. Stand Up To Cancer-supported Clinical Trials Seeking To Extend CAR T-cell Therapy to Solid Tumors, Reported at AACR Annual Meeting  P&T Community
  4. View full coverage on Google News

Published at Sun, 31 Mar 2019 21:00:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • 'Revolutionary' new cancer jab not yet available in Northern Ireland - BBC
    May 4, 2026
  • Thousands of cancer patients in England to benefit from new immunotherapy jab - The Guardian
    May 4, 2026
  • Tens of thousands of cancer patients to benefit from one-minute NHS jab - Sky News
    May 4, 2026
  • NHS cancer jab could save patients hours in hospital - BBC
    May 3, 2026
  • One-minute jab to treat cancer rolled out on NHS - The Telegraph
    May 3, 2026
  • SITC’s Academy of Immuno-Oncology Nominations are Open – SITC - Oncodaily
    May 3, 2026
  • Liquid Biopsies Predict Immunotherapy Response in Breast Cancer Patients, Vanderbilt Study Finds - geneonline.com
    May 3, 2026
  • Liquid biopsy predicts response to breast cancer immunotherapy - Medical Xpress
    May 3, 2026
  • The Targeted Pulse: FDA Decisions and Breakthrough Data Shape Oncology Landscape - Targeted Oncology
    May 3, 2026
  • Top Phase 3 Immunotherapy Trials at ASCO 2026 - Oncodaily
    May 3, 2026

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com